WHO Quality of Life Scale (WHOQOL-100)

1. Abstract

The World Health Organization Quality of Life 100-item instrument (WHOQOL-100) is an international, cross-culturally developed, multidimensional psychometric instrument designed to assess subjective quality of life (QOL) across diverse populations, clinical cohorts, and healthy demographics. Conceptualized by the World Health Organization Quality of Life Group across 15 collaborative field centers globally, the WHOQOL-100 operationalizes quality of life not merely as the absence of disease or functional impairment, but as an individual’s perception of their position in life in the context of the culture and value systems in which they live, and in relation to their goals, expectations, standards, and concerns. The assessment comprises 100 items partitioned into 24 distinct facets representing six overarching domains: Physical Health (Domain 1), Psychological (Domain 2), Level of Independence (Domain 3), Social Relations (Domain 4), Environment (Domain 5), and Spirituality/Religion/Personal Beliefs (Domain 6), along with a general facet evaluating overall quality of life and general health perceptions. In addition, an optional 32-item importance module evaluates the subjective value respondents place on each facet.

Each item is rated on a standardized 5-point Likert-type scale evaluating intensity, capacity, frequency, or satisfaction across a two-week recall period. Psychometric evaluations across international multicenter validation trials demonstrate robust cross-cultural equivalence, high internal consistency reliability (domain Cronbach's alpha coefficients ranging from .82 to .93; facet alphas generally exceeding .70), excellent test-retest reliability (intraclass correlation coefficients > .80), and confirmed construct, convergent, and discriminant validity across clinical and community samples. Confirmatory factor analysis and structural equation modeling validate both the 24-facet hierarchical configuration and the six-domain second-order architecture. The WHOQOL-100 serves as an international gold standard in epidemiological surveillance, clinical trials, health economics, and psychiatric outcome evaluations.

2. Keywords

WHOQOL-100, World Health Organization, Quality of Life, Psychometrics, Patient-Reported Outcome Measures, Cross-Cultural Assessment, Health-Related Quality of Life, Subjective Well-Being, Multidimensional Scaling, Clinical Epidemiology, Psychiatric Outcomes

3. Authors

The WHOQOL-100 was developed collaboratively by the World Health Organization Quality of Life (WHOQOL) Group, a global consortium established by the Division of Mental Health and Prevention of Substance Abuse at the World Health Organization in Geneva, Switzerland. Key founding researchers and coordinating methodologists include:

• Dr. John Orley — Former Head, Mental Health Programme, World Health Organization, Geneva, Switzerland.
• Dr. Willem Kuyken — Department of Psychology, University of Exeter, United Kingdom; and University of Oxford, United Kingdom.
• Prof. Suzanne M. Skevington — WHO Centre for the Study of Quality of Life, Department of Psychology, University of Bath, and University of Manchester, United Kingdom.
• Prof. Donald L. Patrick — Department of Health Services, University of Washington, Seattle, Washington, USA.
• Dr. Shekhar Saxena — Former Director, Department of Mental Health and Substance Abuse, World Health Organization, Geneva, Switzerland.
• Collaborating Field Research Centers: Multi-center research teams operating across 15 initial international sites including Bangkok (Thailand), Bath (United Kingdom), Beersheva (Israel), Chennai/Madras (India), Melbourne (Australia), New Delhi (India), Panama City (Panama), Seattle (United States), St. Petersburg (Russian Federation), Tokyo (Japan), Zagreb (Croatia), Hong Kong, and Paris (France).

4. Purpose

The primary purpose of the WHOQOL-100 is to provide a comprehensive, scientifically rigorous, and culturally sensitive measure of subjective quality of life. For decades, medicine and health sciences relied predominantly on objective biomedical indicators — such as mortality rates, morbidity statistics, laboratory values, and clinician-rated functional impairment indices — to judge clinical efficacy and population health status. While invaluable, these traditional metrics inherently fail to capture the holistic, lived experience of the patient. The World Health Organization conceptualized the WHOQOL project to operationalize its landmark 1948 constitutional definition of health: “a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity.”

The instrument was designed to serve critical functions across diverse clinical, epidemiological, and health policy domains:

• Clinical Practice and Treatment Monitoring: Clinicians utilize the WHOQOL-100 to evaluate baseline patient functioning, elucidate the perceived burden of chronic illness (e.g., cardiovascular disease, diabetes, HIV/AIDS, cancer, major depressive disorder), identify unrecognized areas of distress, and track therapeutic responsiveness or adverse treatment effects from the patient's perspective.
• Comparative Effectiveness and Pharmacoeconomic Research: In randomized controlled trials (RCTs), pharmaceutical interventions often demonstrate equivalent physiological efficacy while producing disparate profiles of tolerability, psychosocial functioning, and daily living satisfaction. The WHOQOL-100 provides nuanced, multidimensional endpoints supporting cost-utility analyses and regulatory approvals.
• Epidemiological Surveillance and Cross-Cultural Research: Because the WHOQOL-100 was simultaneously developed in multiple global sites using coordinated focus group methodologies rather than translated post hoc from a Western framework, it facilitates valid international epidemiological comparisons of health inequities, aging populations, and community health initiatives.
• Health and Social Policy Formulation: Public health agencies leverage domain-specific WHOQOL profiles (particularly the Environment and Social Relations domains) to allocate municipal resources, evaluate urban planning initiatives, and structure social welfare interventions.

5. Psychological Construct

The WHOQOL Group defines Quality of Life as:

“An individual's perception of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards and concerns.”

This definition frames quality of life as a broad, multi-layered construct influenced by physical health, psychological state, degree of independence, social relationships, personal beliefs, and environmental interactions. The WHOQOL-100 operationalizes this construct across 24 specific facets (with four items per facet) nested hierarchically within six major domains, alongside one 4-item facet addressing overall quality of life and general health perceptions:

Domain 1: Physical Health

• Facet 1: Pain and Discomfort — Evaluates the presence, intensity, and disruption caused by physical pain, bodily sensations, and discomfort (e.g., item 3: To what extent do you feel that physical pain prevents you from doing what you need to do?).
• Facet 2: Energy and Fatigue — Measures the respondent's subjective vitality, stamina, and the extent to which lethargy or chronic fatigue impairs their daily life.
• Facet 3: Sleep and Rest — Assesses nocturnal sleep quality, disturbances, ease of waking, restorative capacity of sleep, and psychological worry linked to insomnia.

Domain 2: Psychological

• Facet 4: Positive Feelings — Measures the frequency and intensity of positive emotional states, such as joy, optimism, life enjoyment, contentment, and psychological flourishing.
• Facet 5: Thinking, Learning, Memory and Concentration — Probes subjective cognitive efficacy, including mental clarity, sustained attention, recall capabilities, and executive decision-making.
• Facet 6: Self-Esteem — Explores feelings of self-worth, personal value, self-confidence, and general satisfaction with one's individual abilities and accomplishments.
• Facet 7: Bodily Image and Appearance — Assesses satisfaction with physical appearance, bodily self-concept, and the presence of body-related distress or behavioral inhibition.
• Facet 8: Negative Feelings — Gauges the frequency, severity, and functional interference of distressing affect, including anxiety, sadness, despair, and depressive mood.

Domain 3: Level of Independence

• Facet 9: Mobility — Examines the perceived ability to ambulate, get around physically, and navigate one's immediate and broader spatial environment.
• Facet 10: Activities of Daily Living (ADL) — Evaluates capacity to perform self-care routines, domestic maintenance, and daily utilitarian tasks without assistance.
• Facet 11: Dependence on Medication or Treatment — Measures the extent to which functional capacity and life satisfaction are contingent upon ongoing pharmacological regimens, medical devices, or clinical therapies.
• Facet 12: Working Capacity — Measures subjective competence, stamina, and satisfaction regarding occupational responsibilities, domestic tasks, and productive work roles.

Domain 4: Social Relations

• Facet 13: Personal Relationships — Assesses the quality, warmth, intimacy, and reciprocal satisfaction experienced in personal relationships, including companionship and mutual support.
• Facet 14: Social Support — Evaluates the perceived availability, responsiveness, and adequacy of emotional and instrumental assistance provided by family networks and peer groups.
• Facet 15: Sexual Activity — Probes satisfaction with sexual relations, fulfillment of intimacy needs, and the psychological impact of sexual dysfunction.

Domain 5: Environment

• Facet 16: Physical Safety and Security — Evaluates feelings of protection against crime, physical harm, external violence, and civil instability in daily life.
• Facet 17: Home Environment — Measures satisfaction with residential conditions, housing adequacy, comfort, privacy, and domestic stability.
• Facet 18: Financial Resources — Investigates subjective financial adequacy, purchasing power relative to basic and aspirational needs, and stress regarding monetary constraints.
• Facet 19: Health and Social Care: Availability and Quality — Evaluates access to, promptness of, and quality of clinical services, medical treatments, and social care infrastructure.
• Facet 20: Opportunities for Acquiring New Information and Skills — Probes educational accessibility, cognitive enrichment, skill acquisition, and access to necessary public information.
• Facet 21: Participation in and New Opportunities for Recreation/Leisure — Examines opportunities for relaxation, recreation, pastimes, and the enjoyment of unstructured discretionary time.
• Facet 22: Physical Environment — Measures perceptions of ecological health, exposure to noise and pollution, climate comfort, and local aesthetic qualities.
• Facet 23: Transport — Assesses accessibility, reliability, adequacy, and freedom of movement afforded by private or public transit systems.

Domain 6: Spirituality/Religion/Personal Beliefs

• Facet 24: Spiritual, Religion and Personal Beliefs — Probes existential meaning, inner coherence, spiritual solace, and whether an individual's worldview provides strength and resilience during adversity.

General Facet: Overall Quality of Life and General Health

• An unnumbered 4-item facet integrated into the protocol assessing overarching global satisfaction with life and subjective health evaluations.

6. Theoretical Framework

The WHOQOL-100 is anchored theoretically in an integrated phenomenological, biopsychosocial, and cross-cultural model of subjective well-being. Historically, quality of life measurement was dominated by two divergent paradigms: the objective-social indicators model (which assessed income, living square footage, life expectancy, and clinical biomarkers) and the functional status model (such as Karnofsky Performance Scale or Sickness Impact Profile, which quantified physical disability and limitation). The WHOQOL conceptual framework rejected the notion that external functional disability or clinical pathophysiology correlates linearly with perceived life quality. Instead, the WHOQOL Group synthesized insights from George Engel's Biopsychosocial Model, cognitive appraisal theory (Richard Lazarus and Susan Folkman), and cultural psychology.

Central to this theoretical framework is subjectivity. Quality of life is conceptualized as an internal, cognitive appraisal process wherein an individual constantly compares their actual, experienced state against an internalized set of subjective expectations, values, and cultural norms (Calman's “gap” model of quality of life). A chronic medical condition (e.g., paraplegia) may drastically reduce functional mobility; however, if the individual possesses strong social support, an accommodating physical environment, and deep spiritual or philosophical meaning, their subjective quality of life may remain exceptionally high. Conversely, an individual with no biomedical pathology living in a high-stress, socially isolated, or unsafe environment may report profound reductions in subjective quality of life.

A second foundational pillar of the WHOQOL theoretical architecture is universal cross-cultural equivalence. Prior psychometric instruments were overwhelmingly developed within Western European or North American contexts and subsequently translated into other languages, creating substantial cultural bias and construct non-equivalence. In contrast, the WHOQOL-100 was derived via a simultaneous, de novo multicenter methodology. Focus groups involving healthy individuals, persons living with diverse physical and psychiatric diseases, and healthcare providers were convened across 15 culturally and economically disparate centers worldwide. Facets were included only if consensus established that the underlying concept was relevant, recognizable, and meaningful across all participating cultures.

7. Validity

The WHOQOL-100 has undergone extensive empirical validation across global clinical, epidemiological, and community cohorts. Psychometric evaluations confirm excellent construct, convergent, discriminant, and predictive validity:

• Discriminant (Known-Groups) Validity: Multi-center international validation studies (WHOQOL Group, 1998; Bonomi et al., 2000) have repeatedly demonstrated that the WHOQOL-100 discriminates between healthy individuals and clinical patient populations across all domains. Significant differences (p < .001) are observed when comparing healthy community cohorts with patients suffering from chronic physical illnesses (e.g., rheumatological diseases, chronic kidney disease, cancer) and psychiatric disorders (major depression, schizophrenia). Furthermore, the scale demonstrates sensitivity to perceived disease severity, showing graded decreases in domain scores across progressively impaired clinical stages.
• Convergent Validity: High convergent validity has been established against legacy health status and well-being scales. Domain 1 (Physical Health) and Domain 3 (Level of Independence) correlate strongly with the physical functioning and bodily pain subscales of the Medical Outcomes Study 36-Item Short Form Survey (SF-36) (r = .65 to .78). Domain 2 (Psychological) demonstrates strong negative correlations with the Beck Depression Inventory (BDI) (r = -.68 to -.74) and the State-Trait Anxiety Inventory (STAI). Domain 4 (Social Relations) correlates moderately to strongly with the Duke-UNC Functional Social Support Questionnaire (r = .58 to .67).
• Predictive and Longitudinal Validity: Prospective observational cohorts show that baseline WHOQOL-100 domain scores independently predict functional recovery, adherence to medical regimens, hospital readmission rates, and all-cause mortality, even after adjusting for baseline clinical indicators, disease stage, and laboratory biomarkers.
• Cross-Cultural Construct Equivalence: Confirmatory multi-group structural modeling demonstrates measurement invariance (metric and structural equivalence) across disparate language versions and cultural contexts, confirming that the 24-facet structure measures identical latent constructs worldwide.

8. Reliability

The WHOQOL-100 exhibits high reliability across diverse study populations and language adaptations:

• Internal Consistency: In the primary international field trials (N > 4,000 across 15 centers), Cronbach's alpha coefficients for the six overarching domains were consistently robust: Physical Health (α = .86 – .91), Psychological (α = .82 – .89), Level of Independence (α = .85 – .90), Social Relations (α = .72 – .83), Environment (α = .88 – .93), and Spirituality/Personal Beliefs (α = .83 – .89). At the facet level, 22 of the 24 facets exhibited alpha values exceeding .70, with many facets (e.g., Pain, Energy, Financial Resources, Working Capacity) consistently surpassing α = .80.
• Test-Retest Reliability: Stability analyses conducted over intervals ranging from 2 to 4 weeks in stable clinical and non-clinical cohorts show excellent intraclass correlation coefficients (ICCs). Domain test-retest coefficients generally range between .78 and .91, indicating that the instrument captures stable underlying constructs while remaining sensitive to genuine clinical changes.
• Inter-Rater and Administration Reliability: When administered via standardized self-report or interviewer-assisted formats (for individuals with low literacy or physical limitations), inter-format equivalence is high (coefficients exceeding .85 across facets).

9. Factor Analysis

The latent structure of the WHOQOL-100 was validated using exploratory factor analysis (EFA) during initial item selection, followed by multi-center confirmatory factor analysis (CFA) and structural equation modeling (SEM):

• Item-to-Facet Architecture: In CFA models testing the first-order structure, items demonstrated substantial and statistically significant factor loadings on their designated facets, with standard standardized loadings consistently exceeding .60 (and many loading > .75). Items within each 4-item facet demonstrated high communality and minimal cross-loadings onto alternative facets.
• Second-Order Factor Models: The original WHOQOL-100 configuration established a second-order model containing six broad latent factors representing the six validated domains (Physical, Psychological, Independence, Social Relations, Environment, Spirituality). Goodness-of-fit indices supported this hierarchical organization across international field test data, yielding a Comparative Fit Index (CFI) > .90, Tucker-Lewis Index (TLI) > .90, and Root Mean Square Error of Approximation (RMSEA) < .055.
• Evolution to the 4-Domain WHOQOL-BREF: Subsequent structural equation modeling on large cross-national samples revealed substantial collinearity between the Physical Health and Level of Independence domains, as well as between the Psychological and Spirituality facets. These empirical findings directly informed the creation of the abbreviated 26-item WHOQOL-BREF, which consolidates the six domains into four overarching dimensions: Physical, Psychological, Social Relationships, and Environment (with Spirituality embedded within Psychological). Nevertheless, the comprehensive 6-domain, 24-facet structure of the WHOQOL-100 remains the preferred operational model when detailed diagnostic and facet-level profiling is clinically or scientifically required.

10. Instrument / Measurement Tool

• Instrument Type: Comprehensive, multidimensional, self-administered patient-reported outcome measure (PROM) / psychometric rating scale (interviewer-administered format available for individuals with physical or cognitive impairments).
• Item Count: 100 core assessment items (partitioned into 24 specific facets + 1 general health/QOL facet, each containing 4 items). An optional 32-item Importance Module is also available.
• Recall Period: Previous two weeks (“over the last two weeks”).
• Response Scales: Standardized 5-point Likert-type scales utilizing nine distinct response anchor sets:
• Scale A (Intensity/Capacity): 1 = Not at all, 2 = A little, 3 = A moderate amount, 4 = Very much, 5 = An extreme amount
• Scale B (Intensity/Difficulty): 1 = Not at all, 2 = Slightly, 3 = Moderately, 4 = Very, 5 = Extremely
• Scale C (Capability): 1 = Not at all, 2 = Slightly, 3 = Moderately, 4 = Very well, 5 = Extremely
• Scale D (Adequacy/Completeness): 1 = Not at all, 2 = A little, 3 = Moderately, 4 = Mostly, 5 = Completely
• Scale E (Satisfaction): 1 = Very dissatisfied, 2 = Dissatisfied, 3 = Neither satisfied nor dissatisfied, 4 = Satisfied, 5 = Very satisfied
• Scale F (Happiness): 1 = Very unhappy, 2 = Unhappy, 3 = Neither happy nor unhappy, 4 = Happy, 5 = Very happy
• Scale G (Evaluation): 1 = Very poor, 2 = Poor, 3 = Neither poor nor good, 4 = Good, 5 = Very good
• Scale H (Frequency): 1 = Never, 2 = Seldom, 3 = Quite often, 4 = Very often, 5 = Always
• Scale I (Importance Module): 1 = Not important, 2 = A little important, 3 = Moderately important, 4 = Very important, 5 = Extremely important
• Scoring and Transformation Rules:
  • Negative items (items assessing pain, fatigue, negative feelings, dependence, and difficulties) must be reverse-scored prior to facet aggregation so that higher scores consistently reflect superior quality of life. Specifically, for reversed 5-point items, values are inverted: (1 → 5), (2 → 4), (3 → 3), (4 → 2), (5 → 1), computed algorithmically as: Reverse Score = 6 - Raw Value.
  • Facet scores are calculated by summing the four constituent items, yielding raw facet scores ranging from 4 to 20.
  • Domain scores are derived by calculating the mean score of the constituent facets within that domain and multiplying by 4, maintaining a standardized 4–20 scale.
  • Linear transformations are routinely applied to convert raw domain scores to a 0–100 metric using the standard formula: Transformed Score = (Raw Score - 4) * (100 / 16).

11. Permissions & Fee and Test Year

The development of the WHOQOL-100 began in 1991, with field trials conducted throughout 1993–1995, and definitive international psychometric validation profiles published between 1995 and 1998. The instrument is copyrighted by the World Health Organization (WHO).

The WHOQOL-100 is widely accessible for academic research, epidemiological investigations, and non-commercial clinical practices. While the World Health Organization encourages the broad utilization of the tool, investigators must adhere to formal licensing protocols:

• Academic and Non-Commercial Research: Free of charge. Users typically register their research protocol or request permission through the designated WHO portal or national coordinating centers.
• Commercial Use and Funded Clinical Trials: Commercial entities, pharmaceutical sponsors, or for-profit healthcare corporations may be subject to contractual review, user agreements, and licensing fees administered through the WHO Press office or designated institutional distributors (e.g., Mapi Research Trust / ePROVIDE).
• Integrity of the Instrument: The WHO stipulates that no modifications, item omissions, facet additions, or unauthorized translations may be executed without formal authorization to maintain international comparability and psychometric standardization.

12. References

• Bonomi, A. E., Patrick, D. L., Bushnell, D. M., & Martin, M. (2000). Validation of the United States' version of the World Health Organization Quality of Life (WHOQOL) instrument. Journal of Clinical Epidemiology, 53(1), 1–12. https://doi.org/10.1016/s0895-4356(99)00123-7
• McDowell, I. (2006). Measuring Health: A Guide to Rating Scales and Questionnaires (3rd ed.). Oxford University Press. https://doi.org/10.1093/acprof:oso/9780195165678.001.0001
• Orley, J., & Kuyken, W. (Eds.). (1994). Quality of Life Assessment: International Perspectives. Springer-Verlag. https://doi.org/10.1007/978-3-642-79123-9
• Skevington, S. M., Bradshaw, J., & Saxena, S. (1999). Selecting national items for the WHOQOL: Conceptual and psychometric considerations. Social Science & Medicine, 48(4), 473–487. https://doi.org/10.1016/s0277-9536(98)00366-0
• The WHOQOL Group. (1993). Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL). Quality of Life Research, 2(2), 153–159. https://doi.org/10.1007/BF00435734
• The WHOQOL Group. (1994). The development of the World Health Organization quality of life assessment instrument (the WHOQOL). In J. Orley & W. Kuyken (Eds.), Quality of life assessment: International perspectives (pp. 41–57). Springer-Verlag.
• The WHOQOL Group. (1995). The World Health Organization Quality of Life assessment (WHOQOL): Position paper from the World Health Organization. Social Science & Medicine, 41(10), 1403–1409. https://doi.org/10.1016/0277-9536(95)00112-k
• The WHOQOL Group. (1998). The World Health Organization Quality of Life Assessment (WHOQOL): Development and general psychometric properties. Social Science & Medicine, 46(12), 1569–1585. https://doi.org/10.1016/s0277-9536(98)00009-4
• The WHOQOL Group. (1998). Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychological Medicine, 28(3), 551–558. https://doi.org/10.1017/s0033291798006667

13. Items of the Scale (Questionnaire)